Valthera Pharma works alongside companies across generics, specialty, biosimilars, and valued-added pharmaceutical products as a commercial execution partner — building and operating market entry and scale-up infrastructure from Day One.
We define a country-specific market entry plan focused on revenue, not theory — what to launch, where, how, and in what order.
We embed in your team and run the launch — partners, operations, go-to-market, and first-year performance.
We stay to operate and optimize — building infrastructure and local capability until the business runs independently.
We are embedded directly into your commercial operations team as an execution partner — not a consultancy.
Every engagement starts with a market entry implementation plan and continues through execution: building partner networks, coordinating cross-functional launches, and operating the commercial infrastructure until it runs independently.
We measure success by commercial outcomes, not deliverables.